• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物成瘾与药物成瘾的共同分子和遗传基础:通过在精神病学中纳入多巴胺激动剂疗法克服多巴胺能低下特质/状态

A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.

作者信息

Gold Mark S, Badgaiyan Rajendra D, Blum Kenneth

机构信息

Departments of Psychiatry & Behavioral Sciences, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA 90033, USA; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA; Rivermend Health Scientific Advisory Board, 2300 Windy Ridge Parkway South East, Suite 210S, Atlanta, GA 30339, USA; Drug Enforcement Administration (DEA) Educational Foundation, Washington, DC, USA.

Laboratory of Advanced Radiochemistry and Molecular and Functioning Imaging, Department of Psychiatry, College of Medicine, University of Minnesota, Minneapolis, MN, USA.

出版信息

Psychiatr Clin North Am. 2015 Sep;38(3):419-62. doi: 10.1016/j.psc.2015.05.011.

DOI:10.1016/j.psc.2015.05.011
PMID:26300032
Abstract

This article focuses on the shared molecular and neurogenetics of food and drug addiction tied to the understanding of reward deficiency syndrome. Reward deficiency syndrome describes a hypodopaminergic trait/state that provides a rationale for commonality in approaches for treating long-term reduced dopamine function across the reward brain regions. The identification of the role of DNA polymorphic associations with reward circuitry has resulted in new understanding of all addictive behaviors.

摘要

本文聚焦于食物成瘾和药物成瘾的共同分子及神经遗传学,这与对奖赏缺乏综合征的理解相关。奖赏缺乏综合征描述了一种多巴胺能减退的特质/状态,这为治疗奖赏脑区多巴胺功能长期减退的通用方法提供了理论依据。DNA多态性与奖赏回路关联作用的确定,带来了对所有成瘾行为的新认识。

相似文献

1
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.食物成瘾与药物成瘾的共同分子和遗传基础:通过在精神病学中纳入多巴胺激动剂疗法克服多巴胺能低下特质/状态
Psychiatr Clin North Am. 2015 Sep;38(3):419-62. doi: 10.1016/j.psc.2015.05.011.
2
Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.大脑奖励中边缘回路的神经化学激活与预防复发和药物渴求有关:一种假说。
Med Hypotheses. 2011 Apr;76(4):576-84. doi: 10.1016/j.mehy.2011.01.005.
3
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.奖赏缺乏综合征(RDS)中常见神经遗传学诊断及多巴胺能功能减退的中脑边缘系统调控:改变康复前景
Curr Neuropharmacol. 2017;15(1):184-194. doi: 10.2174/1570159x13666160512150918.
4
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.在男性精神兴奋剂和多药滥用者长期戒断期间克服 qEEG 异常和奖励基因缺陷:第 2 部分。
Postgrad Med. 2010 Nov;122(6):214-26. doi: 10.3810/pgm.2010.11.2237.
5
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).神经遗传学与脑奖励回路激活中的多巴胺受体超敏性和复发性:提出“剥夺放大复发性治疗”(DART)。
Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087.
6
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?以多巴胺激动剂疗法临床对抗奖赏缺乏综合征(RDS)作为一种范式转变:晚餐吃多巴胺?
Mol Neurobiol. 2015 Dec;52(3):1862-1869. doi: 10.1007/s12035-015-9110-9. Epub 2015 Mar 10.
7
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).遗传成瘾风险评分(GARS):奖赏缺乏综合征(RDS)易感性的分子神经遗传学证据。
Mol Neurobiol. 2014 Dec;50(3):765-96. doi: 10.1007/s12035-014-8726-5. Epub 2014 May 31.
8
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.低多巴胺能与“精准行为管理”(PBM):这是一种代际的家族事务。
Curr Pharm Biotechnol. 2020;21(6):528-541. doi: 10.2174/1389201021666191210112108.
9
Reward deficiency syndrome: genetic aspects of behavioral disorders.奖赏缺乏综合征:行为障碍的遗传学方面
Prog Brain Res. 2000;126:325-41. doi: 10.1016/S0079-6123(00)26022-6.
10
Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.神经遗传学和临床证据表明,神经适应原可能激活大脑奖励回路:提出成瘾候选基因图谱。
J Psychoactive Drugs. 2011 Apr-Jun;43(2):108-27. doi: 10.1080/02791072.2011.587393.

引用本文的文献

1
The neural vulnerabilities in reward processing in gambling disorder.赌博障碍中奖励处理的神经易损性。
J Behav Addict. 2025 Jun 23;14(2):1010-1020. doi: 10.1556/2006.2025.00049. Print 2025 Jul 2.
2
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.解决全球阿片类药物危机:将遗传成瘾风险评估与个性化多巴胺能稳态疗法及意识整合疗法相结合。
J Addict Psychiatry. 2024;8(1):50-95. Epub 2024 Jun 20.
3
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.
可乐定作为α-2A受体激动剂治疗成瘾行为的历史视角:聚焦于阿片类药物依赖
INNOSC Theranostics Pharmacol Sci. 2024;7(3). doi: 10.36922/itps.1918. Epub 2024 Jul 29.
4
Converging vulnerability factors for compulsive food and drug use.强迫性食物和药物使用的趋同脆弱性因素。
Neuropharmacology. 2021 Sep 15;196:108556. doi: 10.1016/j.neuropharm.2021.108556. Epub 2021 Apr 20.
5
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?我们是否应该将基因指导下的“多巴胺稳态”纳入奖励缺乏综合征(RSD)的治疗中,并将其作为一线治疗手段?
Acta Sci Neurol. 2021 Feb 2;4(2):17-24.
6
Alterations in reward network functional connectivity are associated with increased food addiction in obese individuals.奖励网络功能连接的改变与肥胖个体中食物成瘾的增加有关。
Sci Rep. 2021 Feb 9;11(1):3386. doi: 10.1038/s41598-021-83116-0.
7
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.寻找无奖赏缺乏综合征(RDS)的对照:基因成瘾风险测试中的“圣杯”。
Curr Psychopharmacol. 2020;9(1):7-21.
8
Neural and neurocognitive markers of vulnerability to gambling disorder: a study of unaffected siblings.赌博障碍易感性的神经和神经认知标志物:一项未受影响的兄弟姐妹研究。
Neuropsychopharmacology. 2020 Jan;45(2):292-300. doi: 10.1038/s41386-019-0534-1. Epub 2019 Oct 9.
9
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.促多巴胺调节剂(KB220PAM)与纳曲酮联合预防阿片类物质使用障碍复发的证据分析
EC Psychol Psychiatr. 2018 Aug;7(8):564-579. Epub 2018 Jul 30.
10
Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.赌博障碍中奖励机制的神经影像学:综合综述。
Mol Psychiatry. 2019 May;24(5):674-693. doi: 10.1038/s41380-018-0230-2. Epub 2018 Sep 13.